Company profile: MDDX
1.1 - Company Overview
Company description
- Provider of technologies and affordable research applications that unlock insights your data did not reveal, improving efficiency and scalability of multicenter trials; offering nearly a dozen tools used by thousands of researchers in dozens of global research trials.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to MDDX
Causaly
HQ: United Kingdom
Website
- Description: Provider of a biomedical research discovery platform that finds and unlocks hidden evidence in biomedicine to accelerate drug discovery. Offers Causaly Cloud to find, analyze and connect evidence from biomedical documents, a hypothesis generation tool to identify mediators of target-disease effects, and advanced filtering by target class for a granular view of targets for specific diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Causaly company profile →
Labviva
HQ: United States
Website
- Description: Provider of an AI-powered life sciences purchasing and inventory platform that integrates with existing eProcurement software to enhance supply chain transparency and reduce complexity, offering supplier catalog management, comprehensive analytics and real-time reporting, intuitive search, multi-device purchasing, and integrated billing, plus a scientifically enabled application that captures enriched product data from papers to enable direct product comparison.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Labviva company profile →
Trials24
HQ: Germany
Website
- Description: Provider of online patient recruitment solutions for clinical trials worldwide, helping CROs and biopharmaceutical companies find patients beyond site databases. Offers OutSite Patient Recruitment leveraging online platforms and patient organizations, and OutSite Feasibility to assess patient availability before trials, reducing recruitment time by 6+ months with 7–12x ROI and providing 20–65% of randomized patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Trials24 company profile →
Lifebit
HQ: United Kingdom
Website
- Description: Provider of intelligent genomics solutions. Lifebit CloudOS enables unified, secure research over distributed big data, with in situ analysis and connection to disparate datasets for large-scale clinico-genomic programs. Lifebit REAL uses AI to analyze real world data, making biomedical data actionable and accessible for biobanks and genomics initiatives.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lifebit company profile →
Deep Lens
HQ: United States
Website
- Description: Provider of a digital pathology workflow platform enabling pathology groups to collaborate on cancer research and accelerate recruitment of cancer patients for clinical trials at diagnosis. Features include AI-powered image detection, workflow support, collaboration, cloud storage, and built-in APIs for ingesting third-party AI models and EMR integration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Deep Lens company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for MDDX
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to MDDX
2.2 - Growth funds investing in similar companies to MDDX
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for MDDX
4.2 - Public trading comparable groups for MDDX
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →